Normal and infarcted myocardium: Differentiation with cellular uptake of manganese at MR imaging in a rat model

Radiology

Volumn 216, Issue 2, 2000, Pages 524-530

  Bremerich, Jens ^a   Saeed, Maythem ^a   Arheden, Håkan ^a   Hǐggîns, Charles B ^a   Wendland, Michael F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animals; Contrast enhancement; Magnetic resonance (MR); Magnetic resonance (MR), echo planar; Magnetic resonance (MR), inversion recovery; Manganese; Myocardium, infarction; Myocardium, MR

Indexed keywords

MANGANESE; POTASSIUM; POTASSIUM CHANNEL; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DOG; DRUG CLEARANCE; DRUG HALF LIFE; HEART INFARCTION; HEART PERFUSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAXATION TIME; SCINTIGRAPHY;

EID: 0033907237     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.216.2.r00jl14524     Document Type: Article

References (51)

1. Schelbert HR, Ashburn WL, Chauncey DM, Halpern SE. Comparative myocardial uptake of intravenously administered radionuclides. J Nucl Med 1974; 15:1092-1100.
2. Pohost GM, Zir LM, Moore RH, McKusick KA, Guiney TE, Beller GA. Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201. Circulation 1977; 55:294-302.
3. Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323:141-146.
4. Marshall RC, Tillisch JH, Phelps ME, et al. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation 1983; 67:766-778.
5. Schelbert HR, Buxton D. Insights into coronary artery disease gained from metabolic imaging. Circulation 1988; 78:496-505.
6. Smart SC, Sawada S, Ryan T, et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993; 88:405-415.
7. Salustri A, Elhendy A, Garyfallydis P, et al. Prediction of improvement of ventricular function after first acute myocardial infarction using low-dose dobutamine stress echocardiography. Am J Cardiol 1994; 74:853-856.
8. Chauncey DM Jr, Schelbert HR, Halpern SE, et al. Tissue distribution studies with radioactive manganese: a potential agent for myocardial imaging. J Nucl Med 1977; 18:933-936.
9. Atkins HL, Som P, Fairchild RG, et al. Myocardial positron tomography with manganese-52m. Radiology 1979; 133:769-774.
10. Buck A, Nguyen N, Burger C, et al. Quantitative evaluation of manganese-52m as a myocardial perfusion tracer in pigs using positron emission tomography. Eur J Nucl Med 1996; 23:1619-1627.
11. Maynard LS, Cotzias GC. The partition of manganese among organs and intracellular organelles of the rat. J Biol Chem 1955; 214: 489-495.
12. Lauterbur PC, Dias MHM, Rudin AM. Augmentation of tissue water proton spin-lattice relaxation rates by in vivo addition of paramagnetic ions. In: Dutton PL, Leigh JS, Scarpa A, eds. Frontiers of biological energetics. New York, NY: Academic Press, 1978; 752-759.
13. Brady TJ, Goldman MR, Pykett IL, et al. Proton nuclear magnetic resonance imaging of regionally ischemic canine hearts: effect of paramagnetic proton signal enhancement. Radiology 1982; 144:343-347.
14. Goldman MR, Brady TJ, Pykett IL, et al. Quantification of experimental myocardial infarction using nuclear magnetic resonance imaging and paramagnetic ion contrast enhancement in excised canine hearts. Circulation 1982; 66:1012-1016.
15. Mendonca-Dias MH, Gaggelli E, Lauterbur PC. Paramagnetic contrast agents in nuclear magnetic resonance medical imaging. Semin Nucl Med 1983; 13:364-376.
16. Wolf GL, Baum L. Cardiovascular toxicity and tissue proton T1 response to manganese injection in the dog and rabbit. AJR Am J Roentgenol 1983; 141:193-197.
17. Schaefer S, Lange RA, Kulkarni PV, et al. In vivo nuclear magnetic resonance imaging of myocardial perfusion using the paramagnetic contrast agent manganese gluconate. J Am Coll Cardiol 1989; 14:472-480.
18. Wendland MF, Saeed M, Geschwind JF, Mann JS, Brasch RC, Higgins CB. Distribution of intracellular, extracellular, and intravascular contrast media for magnetic resonance imaging in hearts subjected to reperfused myocardial infarction. Acad Radiol 1996; 3:S402-S404.
19. Elizondo G, Fretz CJ, Stark DD, et al. Preclinical evaluation of Mn-DPDP: new paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 1991; 178:73-78.
20. Pflugfelder PW, Wendland MF, Holt WW, et al. Acute myocardial ischemia: MR imaging with Mn-TP. Radiology 1988; 167:129-133.
21. Pomeroy OH, Wendland M, Wagner S, et al. Magnetic resonance imaging of acute myocardial ischemia using a manganese chelate, Mn-DPDP. Invest Radiol 1989; 24:531-536.
22. Saeed M, Wagner S, Wendland MF, Derugin N, Finkbeiner WE, Higgins CB. Occlusive and reperfused myocardial infarcts: differentiation with Mn-DPDP-enhanced MR imaging. Radiology 1989; 172:59-64.
23. Rummeny E, Ehrenheim C, Gehl HB, et al. Manganese-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors: results of clinical phase II trials in Germany including 141 patients. Invest Radiol 1991; 26:S142-S145.
24. Gehl HB, Urhahn R, Bohndorf K, et al. MnDPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience. Radiology 1993; 186:795-798.
25. Hustvedt SO, Grant D, Southern TE, Zech K. Plasma pharmacokinetics, tissue distribution and excretion of MnDPDP in the rat and dog after intravenous administration. Acta Radiol 1997; 38:690-699.
26. Grant D, Zech K, Holtz E. Biodistribution and in vivo stability of manganese dipyridoxyl diphosphate in relation to imaging efficacy. Invest Radiol 1994; 29:S249-S250.
27. Gallez B, Bacic G, Sivartz HM. Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP. Magn Reson Med 1996; 35:14-19.
28. Toft KG, Hustvedt SO, Grant D, et al. Metabolism and pharmacokinetics of MnDPDP in man. Acta Radiol 1997; 38:677-689.
29. Rocklage SM, Cacheris WP, Quay SC, Hahn FE, Raymond KN. Manganese(II)N,N′-dipyridoxylethylenediamine-N,N′-diacetate-5, 5′-bis(phosphate): synthesis and characterization of a paramagnetic chelate for magnetic resonance imaging enhancement. Inorg Chem 1989; 28:477-485.
30. Tirkkonen B, Aukrust A, Couture E, et al. Physicochemical characterisation of mangafodipir trisodium. Acta Radiol 1997; 38: 780-789.
31. Selye H, Bajusz E, Grasso S, Mendell P. Simple technique for the surgical occlusion of coronary vessels in the rat. Angiology 1960; 11:398-407.
32. Sievers RE, Schmiedl U, Wolfe CL, et al. A model of acute regional myocardial ischemia and reperfusion in the rat. Magn Reson Med 1989; 10:172-181.
33. Hale SL, Kloner RA. Effect of early coronary artery reperfusion on infarct development in a model of low collateral flow. Cardiovasc Res 1987; 21:668-673.
34. Wendland MF, Saeed M, Lauerma K, et al. Alterations in T1 of normal and reperfused infarcted myocardium after Gd-BOPTA versus GD-DTPA on inversion recovery EPI. Magn Reson Med 1997; 37:448-456.
35. Vivaldi MT, Kloner RA, Schoen FJ. Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. Am J Pathol 1985; 121:522-530.
36. Saeed M, Higgins CB, Geschwind JF, Wendand MF. T1-relaxation kinetics of extracellular, intracellular and intravascular MR contrast agents in normal and acutely reperfused infarcted myocardium using echo-planar MI imaging. Eur Radiol 2000; 10:310-318.
37. 2 on cardiac energy metabolism and manganese accumulation: an experimental study in the isolated perfused rat heart. Invest Radiol 1997; 32:205-211.
38. Chapman RA, Ellis D. Uptake and loss of manganese from perfused frog ventricles. J Physiol 1977; 272:355-366.
39. Hunter DR, Haworth RA, Berkoff HA. Cellular manganese uptake by the isolated perfused rat heart: a probe for the sarcolemma calcium channel. J Mol Cell Cardiol 1981; 13:823-832.
40. 2 and MnDPDP on the isolated and perfused rat heart. Invest Radiol 1997; 32:581-588.
41. Brurok H, Schojtt J, Berg K, Karlsson JO, Jynge P. Effects of manganese dipyridoxyl diphosphate, dipyridoxyl diphosphate - , and manganese chloride on cardiac function: an experimental study in the Langendorff perfused rat heart. Invest Radiol 1995; 30:159-167.
42. Brurok H, Schjott J, Berg K, Karlsson JO, Jynge P. Manganese and the heart: acute cardiodepression and myocardial accumulation of manganese. Acta Physiol Scand 1997; 159: 33-40.
43. 2. Acta Radiol 1997; 38: 740-749.
44. Brurok H, Ardenkjaer-Larsen JH, Hansson G, et al. Manganese dipyridoxyl diphosphate: MRI contrast agent with antioxidative and cardioprotective properties? Biochem Biophys Res Commun 1999; 254:768-772.
45. Ni Y, Marchal G, Herijgers P, et al. Paramagnetic metalloporphyrins: from enhancers of malignant tumors to markers of myocardial infarcts. Acad Radiol 1996; 3:S395-S397.
46. Marchai G, Ni Y, Herijgers P, et al. Paramagnetic metalloporphyrins: infarct avid contrast agents for diagnosis of acute myocardial infarction by MRI. Eur Radiol 1996; 6:2-8.
47. Geschwind JF, Wendland MF, Saeed M, Lauerma K, Derugin N, Higgins CB. AUR Memorial Award: identification of myocardial cell death in reperfused myocardial injury using dual mechanisms of contrast-enhanced magnetic resonance imaging. Acad Radiol 1994; 1:319-325.
48. Pereira RS, Prato FS, Sykes J, Wisenbery G. Assessment of myocardial viability using MRI during a constant infusion of Gd-DTPA: further studies at early and late periods of reperfusion. Magn Reson Med 1999; 42:60-8.
49. 9mTc-DTPA autoradiography in rats. Radiology 1999; 211:698-708.
50. Judd RM, Lugo-Olivieri CH, Arai M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995; 92:1902-1910.
51. Kramer CM, Rogers WJ, Geskin G, et al. Usefulness of magnetic resonance imaging early after acute myocardial infarction. Am J Cardiol 1997; 80:690-695.